Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Liquidia Technologies

Liquidia Technologies
2004 FOUNDED
PUBLIC STATUS
61-70 EMPLOYEES
LQDA STOCK SYMBOL
$7.73 SHARE PRICE (As of Thursday Closing)
Description

Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • 419 Davis Drive
  • Suite 100
  • Morrisville, NC 27560
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Liquidia Technologies’s full profile, request a free trial.

Liquidia Technologies Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$7.21 - $38.46 $144M $7.71 $0.32 80.3K 18.6M

Liquidia Technologies Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 185,275 299,720
Revenue 1,781 2,707 7,258 13,217
EBITDA (36,679) (32,909) (15,212) (15,211)
Net Income (39,394) (53,136) (29,154) (15,934)
Total Assets 73,720 49,418 14,844 8,487
Total Debt 13,070 12,773 22,146 8,682
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Liquidia Technologies Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Liquidia Technologies‘s full profile, request access.

Request full access to PitchBook

Liquidia Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Liquidia Technologies‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Liquidia Technologies Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ocular Therapeutix Formerly VC-backed Bedford, MA 000 00000 00000000000 00000
0000000 Venture Capital-Backed San Diego, CA 00 000.00 0000000000 0 000.00
0000000 Formerly VC-backed Jena, Germany 00 00000 00000000 00000
00000000 000000000 Corporation Watertown, MA 00 00000 000000000 00 00000
0000000 0000000 Failed Transaction (M&A) Mississauga, Canada 000 00000 000000&0
To view this company’s complete list of competitors, request access »

Liquidia Technologies Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Liquidia Technologies‘s full profile, request access.

Request full access to PitchBook

Liquidia Technologies Executive Team (22)

Name Title Board
Seat
Contact
Info
Neal Fowler Chief Executive Officer & Board Member
Kevin Gordon President & Chief Financial Officer
Robert Lippe Chief Operations Officer
Timothy Albury Senior Vice President & Chief Accounting Officer
Jeff Kindig Director, Analytical

8 Former Executives

You’re viewing 5 of 22 executives. Get the full list »

Liquidia Technologies Board Members (13)

Name Representing Role Since Contact
Info
Arthur Kirsch Self Board Member 000 0000
Edward Mathers New Enterprise Associates Board Member 000 0000
Isaac Cheng MD Morningside Group Board Member 000 0000
Jason Rushton Xeraya Capital Board Member 000 0000
Joseph DeSimone Ph.D Self Co-Founder, Scientific Advisor & Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 13 board members. Get the full list »